GC
PRTA icon

Guggenheim Capital’s Prothena Corp PRTA Stock Holding History

Guggenheim Capital’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-43,248
Closed -$893K – 1926
2024
Q2 		$893K Sell
43,248
-1,152
-3% -$24.9K 0.01% 1181
2024
Q1 		$1.1M Buy
44,400
+20,939
+89% +$623K 0.01% 1145
2023
Q4 		$853K Buy
23,461
+8,118
+53% +$312K 0.01% 1234
2023
Q3 		$740K Buy
15,343
+163
+1% +$9.68K 0.01% 1236
2023
Q2 		$1.04M Sell
15,180
-2,210
-13% -$143K 0.01% 1146
2023
Q1 		$843K Buy
+17,390
New +$919K 0.01% 1265
2022
Q4 		– Sell
-75,795
Closed -$4.59M – 1968
2022
Q3 		$4.59M Sell
75,795
-421
-0.6% -$13.3K 0.04% 534
2022
Q2 		$2.07M Buy
+76,216
New +$2.23M 0.02% 873
2018
Q2 		– Sell
-98,323
Closed -$3.61M – 2545
2018
Q1 		$3.61M Buy
98,323
+20,339
+26% +$740K 0.01% 1215
2017
Q4 		$2.92M Buy
77,984
+6,143
+9% +$313K 0.01% 1380
2017
Q3 		$4.65M Buy
71,841
+15,027
+26% +$920K 0.01% 1110
2017
Q2 		$3.07M Sell
56,814
-6,893
-11% -$367K 0.01% 1311
2017
Q1 		$3.56M Buy
63,707
+1,949
+3% +$102K 0.01% 1234
2016
Q4 		$3.04M Sell
61,758
-18,038
-23% -$995K 0.01% 1345
2016
Q3 		$4.79M Buy
79,796
+6,212
+8% +$333K 0.01% 1038
2016
Q2 		$2.57M Sell
73,584
-32,988
-31% -$1.44M 0.01% 1404
2016
Q1 		$4.39M Buy
106,572
+36,960
+53% +$1.45M 0.01% 1066
2015
Q4 		$4.74M Sell
69,612
-139,979
-67% -$8.44M 0.01% 1047
2015
Q3 		$9.5M Buy
209,591
+14,053
+7% +$818K 0.03% 773
2015
Q2 		$10.3M Buy
195,538
+4,472
+2% +$176K 0.03% 819
2015
Q1 		$7.29M Sell
191,066
-10,516
-5% -$270K 0.02% 993
2014
Q4 		$4.18M Sell
201,582
-13,823
-6% -$288K 0.01% 1216
2014
Q3 		$4.77M Sell
215,405
-27,606
-11% -$585K 0.01% 1226
2014
Q2 		$5.48M Sell
243,011
-22,164
-8% -$554K 0.01% 1128
2014
Q1 		$10.2M Buy
265,175
+13,830
+6% +$446K 0.03% 846
2013
Q4 		$6.67M Buy
+251,345
New +$6.3M 0.02% 972

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Guggenheim Capital's PRTA Position: Q3 2024 in Review

Guggenheim Capital sold out of Prothena Corp (PRTA) in Q3 2024, closing a stake of 43,248 shares — an estimated $893K sold.

Guggenheim Capital first reported a position in PRTA in Q4 2013 and held it in 26 quarters. The position peaked at $10.3M in Q2 2015. 164 funds tracked by Wall St. Rank hold PRTA as of Q3 2024.

  • Guggenheim Capital reported no remaining Prothena Corp position as of Q3 2024 after selling out during the quarter.
  • Guggenheim Capital sold 43,248 Prothena Corp shares in Q3 2024, an estimated $893K.
  • Guggenheim Capital first reported a position in Prothena Corp in Q4 2013 and held it in 26 quarters.
  • Guggenheim Capital's Prothena Corp position peaked at $10.3M in Q2 2015.
  • 164 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2024.

Based on Guggenheim Capital's 13F filing for Q3 2024, filed 13 Nov 2024.